Reneo Pharmaceuticals (RPHM) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free RPHM Stock Alerts $1.66 +0.01 (+0.61%) (As of 03:57 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBML Capital Management LLC Makes New Investment in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)marketbeat.com - April 24 at 5:18 AMReneo Pharmaceuticals Inc.thestreet.com - April 14 at 1:20 PMReneo Pharmaceuticals (NASDAQ:RPHM) Trading Up 0.6%marketbeat.com - April 3 at 2:35 AMSell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price Targetmarkets.businessinsider.com - March 31 at 7:14 PMReneo Pharmaceuticals: Q4 Earnings Insightsbenzinga.com - March 28 at 4:09 PMRPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023investorplace.com - March 28 at 2:01 PMReneo Pharmaceuticals, Inc.: Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Updatefinanznachrichten.de - March 28 at 10:52 AMReneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Updateglobenewswire.com - March 28 at 7:35 AMReneo Pharmaceuticals, Inc. (RPHM)uk.finance.yahoo.com - February 14 at 12:17 AMReneo Pharmaceuticals, Inc. (RPHM)uk.finance.yahoo.com - February 14 at 12:17 AMReneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Consensus Recommendation of "Reduce" from Brokeragesmarketbeat.com - February 2 at 1:20 AMReneo Pharmaceuticals Inc (RPHM)investing.com - January 30 at 1:28 AMWhy Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionmsn.com - December 27 at 3:51 PMAnalysts Offer Insights on Healthcare Companies: Rain Therapeutics (RAIN), Reneo Pharmaceuticals (RPHM) and Bicycle Therapeutics (BCYC)markets.businessinsider.com - December 19 at 5:49 PMHold Rating on Reneo Pharmaceuticals Following Lead Drug Trial Failure and Strategic Uncertaintymarkets.businessinsider.com - December 16 at 9:33 AMJefferies Downgrades Reneo Pharmaceuticals (RPHM)msn.com - December 16 at 9:33 AMReneo (RPHM) Plummets 83% on Failure of Metabolic Disorder Studyfinance.yahoo.com - December 15 at 12:31 PMReneo Pharmaceuticals (NASDAQ:RPHM) Rating Reiterated by Jefferies Financial Groupmarketbeat.com - December 15 at 8:16 AMReneo Pharmaceuticals just downgraded at BofA, here's whyrealmoney.thestreet.com - December 15 at 7:30 AM5 Analysts Have This to Say About Reneo Pharmaceuticalsmarkets.businessinsider.com - December 15 at 7:30 AMReneo Pharmaceuticals just downgraded at Piper Sandler, here's whyrealmoney.thestreet.com - December 15 at 1:35 AMReneo Pharmaceuticals just downgraded at Leerink, here's whyrealmoney.thestreet.com - December 15 at 1:35 AMReneo Pharma Hits All-Time Low on Job Cuts, Halted Mavodelpar Developmentmarketwatch.com - December 14 at 3:34 PMReneo stock plunges 84% as company shuts down lead programmsn.com - December 14 at 3:34 PMWhy Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?finance.yahoo.com - December 14 at 3:34 PMmarketbeat.com - December 14 at 12:41 PMReneo Pharmaceuticals, Inc.: Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)finanznachrichten.de - December 14 at 10:34 AMReneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)finance.yahoo.com - December 14 at 10:34 AMmarketbeat.com - December 14 at 9:55 AMmarketbeat.com - December 14 at 9:05 AMPositive Outlook for Reneo Pharmaceuticals: Promising Clinical Trials and Strong Financial Position Underpin Buy Recommendationmarkets.businessinsider.com - November 16 at 10:19 PMReneo: Mavodelpar Data Expected December Of 2023seekingalpha.com - November 16 at 5:18 PMWilliam Blair Initiates Coverage of Reneo Pharmaceuticals (RPHM) with Outperform Recommendationnasdaq.com - November 16 at 1:51 AMWilliam Blair starts Reneo at outperform, cites mitochondrial disorders drugmsn.com - November 15 at 3:14 PMReneo Pharmaceuticals Stock (NASDAQ:RPHM) Earnings Dates and Earning Callsbenzinga.com - November 14 at 11:43 PMReneo Pharmaceuticals GAAP EPS of -$0.57msn.com - November 14 at 6:43 PMReneo Pharmaceuticals Inc RPHMmorningstar.com - November 13 at 7:55 PMReneo Pharmaceuticals Inc (RPHM) Reports Q3 2023 Financial Resultsfinance.yahoo.com - November 13 at 7:55 PMRecap: Reneo Pharmaceuticals Q3 Earningsbenzinga.com - November 13 at 9:54 AMReneo Pharmaceuticals Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 13 at 9:54 AMReneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetingsfinance.yahoo.com - October 25 at 12:56 PMReneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)finance.yahoo.com - October 9 at 10:33 AMReneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summitfinance.yahoo.com - October 6 at 1:16 PMCONDUIT PHARMACEUTICALS INCfinanznachrichten.de - September 26 at 4:55 AMPrelude Capital Management LLC Invests $89,000 in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM)marketbeat.com - September 22 at 4:16 AMReneo Pharmaceuticals (NASDAQ:RPHM) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - September 20 at 8:06 AMHC Wainwright & Co. Reiterates Reneo Pharmaceuticals (RPHM) Buy Recommendationmsn.com - September 8 at 5:15 PMHC Wainwright Reiterates Buy Rating for Reneo Pharmaceuticals (NASDAQ:RPHM)marketbeat.com - September 8 at 11:30 AMH.C. Wainwright Keeps Their Buy Rating on Reneo Pharmaceuticals (RPHM)markets.businessinsider.com - September 8 at 9:13 AMHC Wainwright starts Reneo at buy, sees possible 2025 launch for lead drugmsn.com - August 28 at 5:48 PM Get Reneo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. RPHM Media Mentions By Week RPHM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPHM News Sentiment▼1.720.33▲Average Medical News Sentiment RPHM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPHM Articles This Week▼11▲RPHM Articles Average Week Get Reneo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VAXX News Today FIXX News Today IMRX News Today KZR News Today SCYX News Today GMTX News Today GANX News Today VHAQ News Today CKPT News Today HCWB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPHM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
